Synthesis, molecular docking studies of formononetin derivatives as potent Bax agonists for anticancer activity

Synthesis, Antibacterial Activity, and Molecular Docking Study of Bispyrazole‐Based Derivatives as Potential Antibacterial Agents

(2022) Ghazwan Ali Salman et al.   ChemistrySelect

Isoflavones derived from plant raw materials: bioavailability, anti-cancer, anti-aging potentials, and microbiome modulation

(2021) Saied A. Aboushanab et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer

(2021) Gang Liu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and antitumor activity of new tetrahydrocurcumin derivatives via click reaction

(2021) Meitao Duan et al.   NATURAL PRODUCT RESEARCH

Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer

(2020) Xinyou Yu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Design, synthesis and biological evaluation of 3,5-diaryl isoxazole derivatives as potential anticancer agents

(2020) Derya Anıl Aktaş et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Multicomponent and 1,3-dipolar cycloaddition synthesis of triazole- and isoxazole-acridinedione/xanthenedione heterocyclic hybrids: Cytotoxic effects on human cancer cells

(2020) Abdelkader Naouri et al.   JOURNAL OF MOLECULAR STRUCTURE

Design, synthesis, and biological evaluation of new quinoline-based heterocyclic derivatives as novel antibacterial agents

(2020) Ghazwan Ali Salman et al.   MONATSHEFTE FUR CHEMIE

Schiff Bases of Tetrahydrocurcumin as Potential Anticancer Agents

(2019) Ahmed Mahal et al.   ChemistrySelect

Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway

(2019) Qianmei Zhou et al.   Evidence-based Complementary and Alternative Medicine

Emerging therapies for small cell lung cancer

(2019) Sen Yang et al.   Journal of Hematology & Oncology

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

(2019) Yuening Xiang et al.   Cancer Medicine

Formononetin: A Review of Its Anticancer Potentials and Mechanisms

(2019) Kai-Ching Tay et al.   Frontiers in Pharmacology

Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer

(2019) Gang Liu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

(2019) Hua Luo et al.   Chinese Medicine

Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer

(2018) Andrea Bistrović et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation

(2018) Sunwoo Park et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells

(2018) Jing Zhang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Two new 2,5-diketopiperazines produced by Streptomyces sp. SC0581

(2017) Li Yang et al.   Phytochemistry Letters

Synthesis and Biological Evaluation of 1,2,3-triazole tethered Pyrazoline and Chalcone Derivatives

(2016) Syed Mohammed Ali Hussaini et al.   Chemical Biology & Drug Design

Small-molecule Bax agonists for cancer therapy

(2014) Meiguo Xin et al.   Nature Communications

Apoptosis and Molecular Targeting Therapy in Cancer

(2014) Mohamed Hassan et al.   Biomed Research International

Formononetin-induced Apoptosis of Human Prostate Cancer Cells Through ERK1/2 Mitogen-activated Protein Kinase Inactivation

(2012) Y. Ye et al.   HORMONE AND METABOLIC RESEARCH